X

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

eMAR

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

eMAR

Hospital Drug Shortages

By: Hamid Razaki, PharmD - Drug shortages seen across pharmacies in the United States continue to be an issue in…

eMAR

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

eMAR

Expanding a Technician’s Role

By: Sang Hyo Kim, Staff Editor - Pharmacy, like much of medicine, is constantly changing, and the new changes in…

eMAR

Possible Mandatory Lung Cancer Screening

By: Jenny Park, PharmD Candidate c/o 2015 - Lung cancer takes away the lives of about 160,000 individuals annually, which…

eMAR

Provider Status for Pharmacists: Call to Action or Distant Dream?

By: Samantha Schmidt, PharmD Candidate c/o 2014, Palm Beach Atlantic University - The role of pharmacists in healthcare has grown…

eMAR

Meet the President: An Interview with Father Levesque

By: Beatrice Popovitz, Staff Editor and Ada Seldin, Staff Editor -       In August 2013, St. John’s University welcomed…

eMAR

Advancements Towards a Malaria Vaccine

By: Sang Hyo Kim, Staff Editor - A new experimental vaccine, PfsPZ, offers great promise as a cure for malaria.…

eMAR

Middle East Respiratory Syndrome (MERS)

By: Uzma Toppa, PharmD Candidate c/o 2014 - Middle East Respiratory Syndrome, also known as MERS, is a viral respiratory…

eMAR